Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Children 5 Through 11 Years of Age in European Union Read more
Kineret authorised for emergency use by FDA for the treatment of COVID-19 related pneumonia Read more
Sanofi and GSK’s next-generation COVID-19 booster vaccine VidPrevtyn Beta approved by the European Commission Read more
Libtayo (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Read more
NRG Therapeutics Announces £16 million Series A to Advance Mitochondrial Therapeutics for Parkinson’s and ALS Read more
Royalty Pharma Agrees to Acquire Royalty Interest in Olpasiran from Arrowhead for $250 Million and Future Milestones Read more
Sun Pharma and SPARC enter into a license agreement for commercialization of phenobarbital for injection in the US Read more